Evidence map›Paper›PMID 29854315›Full record

ArticleOncotarget2018

Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.

Stefania Augeri, Stefania Capano, Simona Morone, Giulia Fissolo, Alice Giacomino, Silvia Peola, Zahida Drace, Ida Rapa, Silvia Novello, Marco Volante and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Stefania Augeri *Laboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Stefania Capano *Laboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Simona MoroneLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Giulia FissoloLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Alice GiacominoLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Silvia PeolaLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Zahida DraceLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Ida RapaDepartment of Oncology, University of Torino, San Luigi Hospital, Torino 10043, Italy.
Silvia NovelloDepartment of Oncology, University of Torino, San Luigi Hospital, Torino 10043, Italy.
Marco VolanteDepartment of Oncology, University of Torino, San Luigi Hospital, Torino 10043, Italy.
Luisella RighiDepartment of Oncology, University of Torino, San Luigi Hospital, Torino 10043, Italy.
Enza FerreroLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Erika OrtolanLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
Ada FunaroLaboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino 10126, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCD157/Bst1 glycoprotein is expressed in >85% of malignant pleural mesotheliomas and is a marker of enhanced tumor aggressiveness.

results

conclusionsEvaluation of soluble CD157 in pleural effusions provides a diagnostic aid in malignant mesothelioma.

methodsSoluble CD157 (sCD157) was detected biochemically in culture supernatants of malignant and non-malignant mesothelial cells, and in pleural effusions from various pathological conditions. An ELISA system was established to measure the concentration of sCD157 in fluids, and extended to analyze sCD157 in pleural effusions from a cohort of 295 patients.

Indexed as

biomarkerCD157/Bst1diagnosismesotheliomapleural effusion

Identifiers

PMID29854315
PMCPMC5978265
OpenAlexW2800854412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.